Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients

Authors
Category Primary study
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: b9be8bbd7ca36319949ee898e661c6fee2a6e9c2
First added on: Feb 08, 2025